PEPCLUB

.me
Peptide Intelligence
Cognitive HealthArticlePremium

Selank

5mg Vial
10mg Vial
29 August 2026Updated 29 August 2026
This is Premium content Premium

Create a free account, then upgrade to Premium or Lifetime to unlock the full research article, mechanism of action, results timeline, dosing protocol, and dose calculator for Selank.

Full range of benefits for Selank

Reduces anxiety-like behavior in clinical and preclinical studies

Improves attention and concentration in short-term studies

Enhances memory consolidation and learning in research

Modulates monoamine systems (serotonin, dopamine) and GABA

Increases BDNF expression and supports neuroplasticity in models

Shows neuroprotective and anti-inflammatory effects in models

Non-sedating anxiolytic profile versus benzodiazepines in studies

Administered intranasally for rapid central nervous system delivery

May attenuate stress-induced cortisol responses in studies

Exhibits immunomodulatory effects consistent with tuftsin derivatives

This peptide's combination-safety and interaction data below always stays visible, regardless of membership.

Warning

Important information. The data compiled from scientific literature is provided for educational purposes. Dosage ranges reflect what is reported in studies and do not constitute a recommendation, prescription, or usage guidance. Health decisions should always be made with a qualified professional.

Peptide Interactions

// 14 known interactions

Generally well-tolerated alongside this peptide

Omega-3 fatty acids (EPA/DHA)

Supportive for brain health with no known pharmacokinetic interaction and generally neutral co-administration profile with Selank.

Vitamin B complex

Nutritional support for neurotransmitter synthesis and cognitive function without direct interaction with Selank.

Magnesium supplements

Common adjunct for anxiety and sleep that does not have known adverse interactions with Selank and is generally well tolerated.

All interaction categories

Synergistic (3)

  • Buspirone: Complementary 5-HT1A agonist anxiolytic activity may augment Selank's anxiolytic effects via complementary serotonergic/GABAergic modulation.
  • Piracetam (racetam nootropics): Cognitive-enhancing racetams may produce additive improvements in memory and cognitive function when combined with Selank's nootropic profile.
  • L-theanine: Amino acid with anxiolytic and relaxation-promoting effects that can reinforce Selank's calming and cognitive benefits through GABA/glutamate modulation.

Compatible (3)

  • Omega-3 fatty acids (EPA/DHA): Supportive for brain health with no known pharmacokinetic interaction and generally neutral co-administration profile with Selank.
  • Vitamin B complex: Nutritional support for neurotransmitter synthesis and cognitive function without direct interaction with Selank.
  • Magnesium supplements: Common adjunct for anxiety and sleep that does not have known adverse interactions with Selank and is generally well tolerated.

Monitor (4)

  • Benzodiazepines: Possible additive CNS depressant and sedative effects warrant monitoring of sedation, respiratory status, and consideration of benzodiazepine dose reduction.
  • Selective serotonin reuptake inhibitors (SSRIs): Overlapping effects on serotonergic systems may require clinical monitoring for excessive serotonergic effects and assessment of therapeutic response.
  • Immunosuppressants / cytokine biologics (e.g., anti-TNF agents): Selank's immunomodulatory actions could alter cytokine profiles or immune responses, so immune markers and infection risk should be monitored.
  • Monoamine oxidase inhibitors (MAOIs): Because Selank can modulate monoaminergic signaling, co-administration with MAOIs requires monitoring for hypertensive or serotonergic adverse reactions.

Avoid (4)

  • Pregnancy and breastfeeding: Insufficient human safety data on reproductive and neonatal effects, so use only if benefits clearly outweigh risks and after specialist review.
  • Severe immunodeficiency or active autoimmune disease: Selank's immune-modulating properties could unpredictably affect disease activity and should be used only after careful specialist evaluation.
  • Concomitant CNS depressants (alcohol, opioids, sedative-hypnotics): Potential for additive sedation and respiratory depression mandates careful evaluation and avoidance where feasible.
  • History of bipolar disorder or psychosis: Modulation of monoaminergic and cognitive systems could theoretically precipitate mood switching or psychotic symptoms, requiring psychiatric assessment before use.